These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13969631)

  • 1. Soluble protective antigen from Bordetella pertussis prepared with sodium desoxycholate.
    BARTA G
    J Immunol; 1963 Jan; 90():72-80. PubMed ID: 13969631
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the soluble fraction of Bordetella pertussis isolated with sodium desoxycholate].
    Soare I; Barber C; Dumitresco M
    Arch Roum Pathol Exp Microbiol; 1964 Dec; 23(4):839-44. PubMed ID: 4284319
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunological studies with the desoxycholate extract of Bordetella pertussis according to Barta].
    Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Jun; 130(5):461-9. PubMed ID: 4294232
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sodium desoxycholate extract according to Barta from Bordetella pertussis as an antigen for the serological antibody demonstration in the complement fixation reaction and in latex slide test].
    Hering H; Mochmann H; Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1966 Feb; 130(2):149-54. PubMed ID: 4297442
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigens of Bordetella pertussis. III. The protective antigen.
    MUNOZ J; HESTEKIN BM
    Proc Soc Exp Biol Med; 1963 Mar; 112():799-805. PubMed ID: 13936641
    [No Abstract]   [Full Text] [Related]  

  • 6. Interconnexion between the protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    JOO I; PUSZTAI Z
    Nature; 1960 Oct; 188():331-2. PubMed ID: 13790658
    [No Abstract]   [Full Text] [Related]  

  • 7. The separation of a protective antigen from a toxin-producing strain of Hemophilus pertussis.
    ROBBINS KC; PILLEMER L
    J Immunol; 1950 Oct; 65(4):393-406. PubMed ID: 14794902
    [No Abstract]   [Full Text] [Related]  

  • 8. Protective antigen of haemophilus pertussis.
    PILLEMER L; BLUM L; LEPOW IH
    Lancet; 1954 Jun; 266(6825):1257-60. PubMed ID: 13164367
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adsorption of protective antigen of Hemophilus pertussis on human red cell stromata.
    PILLEMER L
    Proc Soc Exp Biol Med; 1950 Dec; 75(3):704-5. PubMed ID: 14808372
    [No Abstract]   [Full Text] [Related]  

  • 11. On the protective antigen of phase 1 H. pertussis.
    KUWAJIMA Y; MASUI M; SHIMURA N
    Yokohama Med Bull; 1952 Jun; 3(3):131-9. PubMed ID: 13029568
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental relation between histamine-sensitizing factor and the protective antigen of Bordetella pertussis].
    Jiménez Paredes J; Ruiz Puente J; González Pacheco M
    Salud Publica Mex; 1981; 23(6):621-9. PubMed ID: 6278660
    [No Abstract]   [Full Text] [Related]  

  • 13. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis.
    Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME
    Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bordetella pertussis serotypes in Canada.
    Toma S; Lo H; Magus M
    Can Med Assoc J; 1978 Oct; 119(7):722-4. PubMed ID: 213182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. THE CONTENT OF ANTIGENS 1,2 AND 3 IN STRAINS OF BORDETELLA PERTUSSIS AND IN VACCINES.
    CHALVARDJIAN N
    Can Med Assoc J; 1965 May; 92(21):1114-6. PubMed ID: 14285295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The haemagglutinin of Haemophilus pertussis; haemagglutinin as a protective antigen in experimental murine pertussis.
    KEOGH EV; NORTH EA
    Aust J Exp Biol Med Sci; 1948 Jul; 26(Pt 4):315-22. PubMed ID: 18880597
    [No Abstract]   [Full Text] [Related]  

  • 17. The soluble protective antigen and the histamine-sensitizing factor of Bordetella pertussis.
    Pieroni RE; Broderick EJ; Levine L
    J Immunol; 1965 Oct; 95(4):643-50. PubMed ID: 4284676
    [No Abstract]   [Full Text] [Related]  

  • 18. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection.
    Suzuki K; Shinzawa N; Ishigaki K; Nakamura K; Abe H; Fukui-Miyazaki A; Ikuta K; Horiguchi Y
    Microbiol Immunol; 2017 Sep; 61(9):371-379. PubMed ID: 28752940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple chemically defined medium for the production of phase I Bordetella pertussis.
    Stainer DW; Scholte MJ
    J Gen Microbiol; 1970 Oct; 63(2):211-20. PubMed ID: 4324651
    [No Abstract]   [Full Text] [Related]  

  • 20. Bordetella pertussis iron regulated proteins as potential vaccine components.
    Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME
    Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.